KYMERA THERAPEUTICS

kymera-therapeutics-logo

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. It features a proprietary predictive modeling degradation platform with a novel small molecule modality to accelerate the drug discovery designed for disease-causing proteins.

#SimilarOrganizations #People #Financial #Event #Website #More

KYMERA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2017-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.kymeratx.com

Total Employee:
101+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
604 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Wordpress Plugins


Similar Organizations

abata-therapeutics-logo

Abata Therapeutics

Abata Therapeutics is a biotech company.

allay-therapeutics-logo

Allay Therapeutics

Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.

rakuten-medical-logo

Rakuten Medical

Rakuten Medical is a Bio-technology Company.

casma-therapeutics-logo

Casma Therapeutics

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

freeline-logo

Freeline

Freeline Therapeutics is a biotechnology company focused on developing liver directed gene therapies for a range of diseases.

mahana-therapeutics-logo

Mahana Therapeutics

Mahana Therapeutics is a developer of digital treatments for people living with gastrointestinal conditions.

neogene-therapeutics-logo

Neogene Therapeutics

Neogene Therapeutics is a biotech company providing cancer patients with T cell therapies targeting mutated proteins called neo-antigens.

remix-therapeutics-logo

Remix Therapeutics

Remix Therapeutics is a biotechnology company.

seer-logo

Seer

Seer is a biotechnology company that offers tools and solutions related to the field of proteomics.


Current Advisors List

steve-hall_image

Steve Hall Board Member @ Kymera Therapeutics
Board_member

elaine-jones_image

Elaine Jones Board of Directors @ Kymera Therapeutics
Board_member

andrew-hedin_image

Andrew Hedin Board of Directors @ Kymera Therapeutics
Board_member

bruce-booth_image

Bruce Booth Chairman of the Board @ Kymera Therapeutics
Board_member

Current Employees Featured

nello-mainolfi_image

Nello Mainolfi
Nello Mainolfi Founder, President & CEO @ Kymera Therapeutics
Founder, President & CEO
2019-11-01

jared-gollob_image

Jared Gollob
Jared Gollob Chief Medical Officer @ Kymera Therapeutics
Chief Medical Officer
2018-09-01

bruce-jacobs_image

Bruce Jacobs
Bruce Jacobs Chief Financial Officer @ Kymera Therapeutics
Chief Financial Officer
2019-07-01

vijay-sabesan_image

Vijay Sabesan
Vijay Sabesan Senior Vice President, Technical Operations @ Kymera Therapeutics
Senior Vice President, Technical Operations
2021-12-01

karen-weisbach_image

Karen Weisbach
Karen Weisbach Vice President, People and Culture @ Kymera Therapeutics
Vice President, People and Culture
2021-07-01

not_available_image

Jolly Bhatia
Jolly Bhatia Vice President, Quality @ Kymera Therapeutics
Vice President, Quality
2021-07-01

not_available_image

Joanna C. Horobin
Joanna C. Horobin Non Executive Director @ Kymera Therapeutics
Non Executive Director
2018-04-01

elaine-caughey_image

Elaine Caughey
Elaine Caughey Chief Business Officer @ Kymera Therapeutics
Chief Business Officer
2021-06-01

not_available_image

Dax Denman
Dax Denman Sr. Director Program Management @ Kymera Therapeutics
Sr. Director Program Management
2021-08-01

Founder


nello-mainolfi_image

Nello Mainolfi

Stock Details


Company's stock symbol is NASDAQ:KYMR

Investors List

t-rowe-price_image

T. Rowe Price

T. Rowe Price investment in Post-IPO Equity - Kymera Therapeutics

redmile-group_image

Redmile Group

Redmile Group investment in Post-IPO Equity - Kymera Therapeutics

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Post-IPO Equity - Kymera Therapeutics

avoro-capital-advisors_image

Avoro Capital Advisors

Avoro Capital Advisors investment in Post-IPO Equity - Kymera Therapeutics

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Post-IPO Equity - Kymera Therapeutics

biotechnology-value-fund_image

Biotechnology Value Fund

Biotechnology Value Fund investment in Post-IPO Equity - Kymera Therapeutics

solasta-ventures_image

Solasta Ventures

Solasta Ventures investment in Series C - Kymera Therapeutics

redmile-group_image

Redmile Group

Redmile Group investment in Series C - Kymera Therapeutics

blackrock_image

BlackRock

BlackRock investment in Series C - Kymera Therapeutics

bessemer-venture-partners_image

Bessemer Venture Partners

Bessemer Venture Partners investment in Series C - Kymera Therapeutics

Official Site Inspections

http://www.kymeratx.com Semrush global rank: 1.88 M Semrush visits lastest month: 11.68 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Kymera Therapeutics" on Search Engine